Cargando…
Novel Hybrid Peptide Cecropin A (1–8)-LL37 (17–30) with Potential Antibacterial Activity
Hybridizing different antimicrobial peptides (AMPs) is a particularly successful approach to obtain novel AMPs with increased antimicrobial activity but minimized cytotoxicity. The hybrid peptide cecropin A (1–8)-LL37 (17–30) (C-L) combining the hydrophobic N-terminal fragment of cecropin A (C) with...
Autores principales: | Wei, Xu-Biao, Wu, Ru-Juan, Si, Da-Yong, Liao, Xiu-Dong, Zhang, Lu-Lu, Zhang, Ri-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964367/ https://www.ncbi.nlm.nih.gov/pubmed/27367675 http://dx.doi.org/10.3390/ijms17070983 |
Ejemplares similares
-
A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions
por: Wei, Xubiao, et al.
Publicado: (2020) -
Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
por: Lu, Fatai, et al.
Publicado: (2022) -
Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
por: Zhuo, Haiwei, et al.
Publicado: (2022) -
Design and characterization of a new hybrid peptide from LL-37 and BMAP-27
por: Al Tall, Yara, et al.
Publicado: (2019) -
The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure
por: Engelberg, Yizhaq, et al.
Publicado: (2020)